Bausch + Lomb BLCO Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net

Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net at other companies

PBH

Prestige Consumer HealthcarePBH

——

OrganonOGN

——

KenvueKVUE

——

PfizerPFE

——

Other financials

Income statement

See full

Revenue$1.2B+9.4%

Operating income$33.0M+140%

Net income-$71.0M+66.5%

EPS (diluted)-$0.20+66.7%

Balance sheet

See full

Cash & equivalents$279.0M+29.8%

Total debt$5.0B+4.3%

Total equity$6.4B+0.3%

Total assets$13.8B+2.6%

Cash flow

See full

Operating cash flow$32.0M+228%

CapEx$100.0M-9.1%

Free cash flow-$68.0M+49.6%

Valuation

See full

Market cap$5.43B+10.2%

Profitability

See full

Operating margin4.4%+2.9pp

Net margin-4.2%-1.3pp

FCF margin-3.4%0.0pp

Returns & leverage

See full

Return on equity-3.4%-0.9pp

Debt / equity0.8×0.0×

Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's debt instrument, unamortized discount (premium) and debt issuance costs, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bausch + Lomb's debt instrument, unamortized discount (premium) and debt issuance costs, net?: Bausch + Lomb (BLCO) reported debt instrument, unamortized discount (premium) and debt issuance costs, net of $55M in Q1 2026.
How has Bausch + Lomb's debt instrument, unamortized discount (premium) and debt issuance costs, net changed year-over-year?: Bausch + Lomb's debt instrument, unamortized discount (premium) and debt issuance costs, net increased by 5.8% year-over-year, from $52M to $55M.